Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
      COVID-19*/epidemiology ; COVID-19*/prevention & control ; Prisoners*; Humans ; Prisons ; COVID-19 Vaccines/therapeutic use ; Cross-Sectional Studies ; Life Change Events ; SARS-CoV-2 ; Vaccination
    • نبذة مختصرة :
      Background: Evidence has shown that the risk of transmission of SARS-CoV-2 is much higher in prisons than in the community. The release of the COVID-19 vaccine and the recommendation by WHO to include prisons among priority settings have led to the inclusion of prisons in national COVID-19 vaccination strategies. Evidence on prison health and healthcare services provision is limited and often focuses on a single country or institution due to the multiple challenges of conducting research in prison settings. The present study was done in the framework of the EU-founded project RISE-Vac. It aimed to analyse the best practices and challenges applied in implementing COVID-19 universal vaccination services during the pandemic to support future expansion of routine life course vaccination services for people living in prison (PLP).
      Methods: Two online cross-sectional surveys were designed and piloted: survey1 on prison characteristics and (non-COVID-19) immunisation practices; survey2 on the implementation and coverage of COVID-19 vaccination with open-ended questions for thematic analysis. Each RISE-Vac project partner distributed the questionnaire to one or two prisons in their country. Answers were collected from eight European prisons' directors or medical directors between November 2021-May 2022.
      Results: According to our findings, the implementation modalities of COVID-19 vaccination services in the surveyed prisons were effective in improving PLP vaccination coverage. Strategies for optimal management of the vaccination campaign included: periodic time slot for PLP vaccination; new staff recruitment and task shifting; distribution of informational material both to PLP and prison staff. Key challenges included continuity of care after release, immunisation information system, and vaccine hesitancy.
      Conclusions: To the best of our knowledge, this is the first study describing the implementation of COVID-19 vaccination services in European prisons, suggesting that the expansion of vaccination provision in prison is possible. There is no unique solution that will fit every country but commonalities likely to be important in the design and implementation of future vaccination campaigns targeting PLP emerged. Increased availability of vaccination services in prison is not only possible, but feasible and highly desirable, and can contribute to the reduction of health inequalities.
      (© 2024. The Author(s).)
    • References:
      JAMA Netw Open. 2022 Mar 1;5(3):e224862. (PMID: 35353164)
      Epidemiol Infect. 2021 Jan 25;149:e59. (PMID: 33487201)
      Glob Pediatr Health. 2019 Jun 13;6:2333794X19855290. (PMID: 31236433)
      Br J Nurs. 2010 Jun 24-Jul 7;19(12):782-6. (PMID: 20622798)
      J Correct Health Care. 2015 Jul;21(3):265-75. (PMID: 26084948)
      Epidemiol Infect. 2018 Oct;146(13):1689-1691. (PMID: 30021664)
      Health Justice. 2019 Jul 31;7(1):14. (PMID: 31368051)
      J Community Health. 2021 Dec;46(6):1244-1251. (PMID: 33877534)
      Lancet Reg Health Eur. 2021 May;4:100088. (PMID: 33997833)
      Addiction. 2018 Jan;113(1):80-90. (PMID: 28710874)
      Lancet Glob Health. 2021 Apr;9(4):e431-e445. (PMID: 33639097)
      Vaccine. 2022 Mar 31;40 Suppl 1:A10-A16. (PMID: 34593269)
      Psychiatr Serv. 2022 Dec 1;73(12):1409-1411. (PMID: 35652192)
      Lancet Public Health. 2022 Jun;7(6):e569-e572. (PMID: 35660218)
      Int J Environ Res Public Health. 2020 Oct 19;17(20):. (PMID: 33086513)
      Vaccine. 2019 Aug 14;37(35):4906-4919. (PMID: 31327651)
      PLoS One. 2022 Sep 9;17(9):e0267070. (PMID: 36084037)
    • Grant Information:
      001 International WHO_ World Health Organization; 101018353 Third Health Programme
    • Contributed Indexing:
      Keywords: COVID-19; Europe; Health inequities; Prison; Vaccination
    • الرقم المعرف:
      0 (COVID-19 Vaccines)
    • الموضوع:
      Date Created: 20240410 Date Completed: 20240412 Latest Revision: 20240518
    • الموضوع:
      20240518
    • الرقم المعرف:
      PMC11007954
    • الرقم المعرف:
      10.1186/s12889-024-18063-2
    • الرقم المعرف:
      38600540